U-Neuron Biomedical Inc (TPEX: 6973)
Health Care · Biotechnology · TW
NT$37.15
+3.19% today · +0.7% 1Y
U-Neuron Biomedical Inc (TPEX: 6973) operates in the Biotechnology industry within the Health Care sector. The company is valued at $34.31M and employs 30 people.
Over the last twelve months the share price has gained 0.7%, trading between 31.30 and 53.50.
6973 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.31M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.12
- 52-week high
- NT$53.50
- 52-week low
- NT$31.30
- Avg volume (3M)
- —
- Shares outstanding
- 29.55M
- Employees
- 30
- Next earnings
- —
About U-Neuron Biomedical Inc
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.
- ISIN
- TW0006973001
- Founded
- 2015
- Listed since
- Jul 20, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €875.40 | +1.30% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.70 | +2.02% |
Figures last refreshed Aug 18, 2026.